• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Atossa Therapeutics, Inc. - Common Stock (NQ:ATOS)

    5.400 +0.070 (+1.31%)
    Streaming Delayed Price Updated: 9:43 AM EDT, Mar 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,870
    Open 5.370
    Bid (Size) 5.330 (200)
    Ask (Size) 5.490 (100)
    Prev. Close 5.330
    Today's Range 5.370 - 5.420
    52wk Range 3.760 - 19.35
    Shares Outstanding 125,785,200
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
    Issued on behalf of Oncolytics Biotech Inc. 
    From Equity Insider
    Via GlobeNewswire
    News headline image
    ATOS Stock Tumbles 32% — Here’s What Retail Investors Think Of The Reverse Stock Split ↗
    Atossa Therapeutics said last week that its board has approved a reverse stock split of the company’s common stock, at a ratio of 15:1, with an effective time of 12:01 a.m. Eastern Time on February 2,... 
    Via Stocktwits

    Performance

    YTD
    -42.9%
    -42.9%
    1 Month
    +28.3%
    +28.3%
    3 Month
    -49.8%
    -49.8%
    6 Month
    -56.7%
    -56.7%
    1 Year
    -51.9%
    -51.9%

    More News

    Read More
    Get insights into the top gainers and losers of Friday's after-hours session. ↗
    Via Chartmill
    Atossa Therapeutics Stock Jumps After FDA Grants Rare Pediatric Status To DMD Drug — Retail Bets On Phase 3 Fast-Track ↗
    Via Stocktwits
    News headline image
    MicroMarvel - Atossa Therapeutics ↗
    Via Talk Markets
    News headline image
    Why Did ATOS Stock Jump 10% In Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Why Are Shares Of Atossa Therapeutics Up Today? ↗
    Via Benzinga
    News headline image
    Get insights into the top gainers and losers of Thursday's pre-market session. ↗
    Via Chartmill
    News headline image
    NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESS Newswire
    News headline image
    Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESS Newswire
    News headline image
    This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
    Via Benzinga
    News headline image
    Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22
    Via ACCESS Newswire
    News headline image
    Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESS Newswire
    News headline image
    Earnings Scheduled For March 25, 2025 ↗
    Via Benzinga
    News headline image
    Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday ↗
    Via Benzinga
    News headline image
    ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q2 2024 ↗
    Via InvestorPlace
    News headline image
    3 Dirt-Cheap Drug Developers With Blockbuster Potential ↗
    Via InvestorPlace
    News headline image
    3 Penny Stock Moonshots with 300%+ Upside Potential by 2025 ↗
    Via InvestorPlace
    News headline image
    Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar ↗
    Via InvestorPlace
    News headline image
    3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off ↗
    Via InvestorPlace
    News headline image
    Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗
    Via InvestorPlace
    News headline image
    ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q1 2024 ↗
    Via InvestorPlace
    News headline image
    Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar ↗
    Via InvestorPlace
    News headline image
    ATOS Stock Earnings: Atossa Therapeutics Misses EPS for Q4 2023 ↗
    Via InvestorPlace
    News headline image
    Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market ↗
    Via InvestorPlace

    Frequently Asked Questions

    Is Atossa Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Atossa Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Atossa Therapeutics, Inc. - Common Stock trade on?
    Atossa Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Atossa Therapeutics, Inc. - Common Stock?
    The ticker symbol for Atossa Therapeutics, Inc. - Common Stock is ATOS on the Nasdaq Stock Market
    What is the current price of Atossa Therapeutics, Inc. - Common Stock?
    The current price of Atossa Therapeutics, Inc. - Common Stock is 5.400
    When was Atossa Therapeutics, Inc. - Common Stock last traded?
    The last trade of Atossa Therapeutics, Inc. - Common Stock was at 03/23/26 09:43 AM ET
    What is the market capitalization of Atossa Therapeutics, Inc. - Common Stock?
    The market capitalization of Atossa Therapeutics, Inc. - Common Stock is 679.24M
    How many shares of Atossa Therapeutics, Inc. - Common Stock are outstanding?
    Atossa Therapeutics, Inc. - Common Stock has 679M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.